|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
et al: Bladder cancer: Epidemiology, staging, and grading and
diagnosis. Urology. 66 Suppl 6:S4–S34. 2005. View Article : Google Scholar
|
|
3
|
Khan N, Afaq F, Saleem M, Ahmad N and
Mukhtar H: Targeting multiple signaling pathways by green tea
polyphenol (−)-epigallocatechin-3-gallate. Cancer Res.
66:2500–2505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hosono T, Fukao T, Ogihara J, Ito Y, Shiba
H, Seki T and Ariga T: Diallyl trisulfide suppresses the
proliferation and induces apoptosis of human colon cancer cells
through oxidative modification of beta-tubulin. J Biol Chem.
280:41487–41493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu Y, Wu J, Li S, Wang X, Liang Z, Xu X,
Xu X, Hu Z, Lin Y, Chen H, et al: Apigenin inhibits migration and
invasion via modulation of epithelial mesenchymal transition in
prostate cancer. Mol Med Rep. 11:1004–1008. 2015.PubMed/NCBI
|
|
6
|
Wang Q, Xu J, Rottinghaus GE, Simonyi A,
Lubahn D, Sun GY and Sun AY: Resveratrol protects against global
cerebral ischemic injury in gerbils. Brain Res. 958:439–447. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Russo A, Palumbo M, Aliano C, Lempereur L,
Scoto G and Renis M: Red wine micronutrients as protective agents
in Alzheimer-like induced insult. Life Sci. 72:2369–2379. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clément MV, Hirpara JL, Chawdhury SH and
Pervaiz S: Chemopreventive agent resveratrol, a natural product
derived from grapes, triggers CD95 signaling-dependent apoptosis in
human tumor cells. Blood. 92:996–1002. 1998.PubMed/NCBI
|
|
10
|
Aziz MH, Nihal M, Fu VX, Jarrard DF and
Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma
LNCaP cells is mediated via modulation of phosphatidylinositol
3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther.
5:1335–1341. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang HY, Shih A, Cao HJ, Davis FB, Davis
PJ and Lin HY: Resveratrol-induced cyclooxygenase-2 facilitates
p53-dependent apoptosis in human breast cancer cells. Mol Cancer
Ther. 5:2034–2042. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tessitore L, Davit A, Sarotto I and
Caderni G: Resveratrol depresses the growth of colorectal aberrant
crypt foci by affecting bax and p21(CIP) expression.
Carcinogenesis. 21:1619–1622. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Y, Wang H, Liu M, Lin F and Hua J:
Resveratrol abrogates the effects of hypoxia on cell proliferation,
invasion and EMT in osteosarcoma cells through downregulation of
the HIF-1α protein. Mol Med Rep. 11:1975–1981. 2015.PubMed/NCBI
|
|
14
|
Gao Q, Yuan Y, Gan HZ and Peng Q:
Resveratrol inhibits the hedgehog signaling pathway and
epithelial-mesenchymal transition and suppresses gastric cancer
invasion and metastasis. Oncol Lett. 9:2381–2387. 2015.PubMed/NCBI
|
|
15
|
Jiao Y, Li H, Liu Y, Guo A, Xu X, Qu X,
Wang S, Zhao J, Li Y and Cao Y: Resveratrol inhibits the invasion
of glioblastoma-initiating cells via down-regulation of the
PI3K/Akt/NF-κB signaling pathway. Nutrients. 7:4383–4402. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
18
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Shi J, Feng J, Klocker H, Lee C
and Zhang J: Type IV collagenase (matrix metalloproteinase-2 and
−9) in prostate cancer. Prostate Cancer Prostatic Dis. 7:327–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kader AK, Liu J, Shao L, Dinney CP, Lin J,
Wang Y, Gu J, Grossman HB and Wu X: Matrix metalloproteinase
polymorphisms are associated with bladder cancer invasiveness. Clin
Cancer Res. 13:2614–2620. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin J, Wang Y, Bai Y, Yang K, Mao Q, Lin
Y, Kong D, Zheng X and Xie L: Epigallocatechin-3-gallate inhibits
bladder cancer cell invasion via suppression of NF-κB-mediated
matrix metalloproteinase-9 expression. Mol Med Rep. 6:1040–1044.
2012.PubMed/NCBI
|
|
22
|
Waas ET, Wobbes T, Lomme RM, DeGroot J,
Ruers T and Hendriks T: Matrix metalloproteinase 2 and 9 activity
in patients with colorectal cancer liver metastasis. Br J Surg.
90:1556–1564. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guruvayoorappan C and Kuttan G:
Amentoflavone inhibits experimental tumor metastasis through a
regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase,
lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in
lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol.
30:711–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastas
Rev. 22:395–403. 2003. View Article : Google Scholar
|
|
25
|
Crowe DL, Tsang KJ and Shemirani B: Jun
N-terminal kinase 1 mediates transcriptional induction of matrix
metalloproteinase 9 expression. Neoplasia. 3:27–32. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moon SK, Kim HM, Lee YC and Kim CH:
Disialoganglioside (GD3) synthase gene expression suppresses
vascular smooth muscle cell responses via the inhibition of ERK1/2
phosphorylation, cell cycle progression, and matrix
metalloproteinase-9 expression. J Biol Chem. 279:33063–33070. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang BW, Chang H, Lin S, Kuan P and Shyu
KG: Induction of matrix metalloproteinases-14 and −2 by cyclical
mechanical stretch is mediated by tumor necrosis factor-alpha in
cultured human umbilical vein endothelial cells. Cardiovasc Res.
59:460–469. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SJ, Cho SC, Lee EJ, Kim S, Lee SB, Lim
JH, Choi YH, Kim WJ and Moon SK: Interleukin-20 promotes migration
of bladder cancer cells through extracellular signal-regulated
kinase (ERK)-mediated MMP-9 protein expression leading to nuclear
factor (NF-κB) activation by inducing the up-regulation of
p21(WAF1) protein expression. J Biol Chem. 288:5539–5552. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang
Z, Lin J, Li X and Guo Y: CCDC34 is up-regulated in bladder cancer
and regulates bladder cancer cell proliferation, apoptosis and
migration. Oncotarget. 6:25856–25867. 2015. View Article : Google Scholar : PubMed/NCBI
|
